Tempest Therapeutics (TPST)
(Delayed Data from NSDQ)
$1.34 USD
-0.06 (-4.29%)
Updated Aug 8, 2024 04:00 PM ET
Pre-Market: $1.36 +0.02 (1.49%) 9:26 AM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.45 | 0.00% |
Earnings Summary
For their last quarter, Tempest Therapeutics (TPST) reported earnings of -$0.42 per share, beating the Zacks Consensus Estimate of $-0.47 per share. This reflects a positive earnings surprise of 10.64%. Look out for TPST's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.45 per share, reflecting a year-over-year increase of 6.25%.
Earnings History
Price & Consensus
Zacks News for TPST
All You Need to Know About Tempest Therapeutics, Inc. (TPST) Rating Upgrade to Buy
TPST: What are Zacks experts saying now?
Zacks Private Portfolio Services